Glenmark Pharmaceuticals Signs 5-Year CRM Contract

Glenmark Pharmaceuticals has signed a 5-year agreement with Data3s for CRM, a customer relationship management and sales force support platform.

Glenmark Pharmaceuticals is a global, research-driven company with its headquarters located in Mumbai, India, and is one of the main generic medicine providers in central Europe. The company employs over 4100 people around the world and has branded generic formulation interests in more than 95 countries, including India, Europe, Brazil, Latin America, Russia, Africa and Asia.

Glenmark Pharmaceuticals recently began searching for a system that would support the management of other fields, such as medical samples distribution and the distribution of financial documents. Glenmark also wanted a system that would be cost effective.

Glenmark’s National Sales Director shared in a statement that the company is sure the CRM system will be beneficial for the sales, marketing and financial departments and is excited to see the impact this new CRM platform can make.

Data3s, a pharmaceutical CRM company and the creator of eluzzion CRM, proved to be the right fit for Glenmark Pharmaceuticals. The eluzzion CRM solution is a fully integrated CRM/BI solution for pharmaceutical companies with support for financial, logistics and HR decisions.

According to Data3s’ Sales Director, the company is most effective with its CRM solutions when it can serve numerous countries and corporate affiliates together. The company believes this allows for greater standardization without losing the unique demands of each individual country. When more countries operate on the same platform, top management and headquarters tend to be more interested in what is going on in their region.

Data3s believes that its latest developments and now the 5-year contract with Glenmark, reflects the quality of their CRM product and the growing strength of the business.